Of those who were slide-positive , 690/787 ( 87.8 % ) in the intervention arm and 347/392 ( 88.5 % ) in the control arm received an artemisinin combination therapy ( adjusted risk ratio 0.96 ( 0.84 to 1.09 ) ) .